AYTU BIOPHARMA, INC Convertible Notes Payable, Current
AYTU BIOPHARMA, INC (AYTU) had Convertible Notes Payable, Current of $36.49 thousand as of 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-04-15
- 2015-02-28: Convertible Notes Payable, Current $36.49K.
- 2014-11-30: Convertible Notes Payable, Current $31.99K.
- 2014-05-31: Convertible Notes Payable, Current $28.53K.
- 2014-02-28: Convertible Notes Payable, Current $104.95K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2015-02-28 | $36.49K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $31.99K 10-Q · filed 2015-01-12 | |
| 2014-05-31 | $28.53K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $104.95K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $104.95K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $99.51K 10-K · filed 2014-11-26 | |
| 2012-09-30 | $96.14K 10-Q · filed 2013-06-28 | $72.56K 10-Q · filed 2013-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |